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Abstract
An increasing number of genetic variants involved in dyslexia development were discovered during the last years,
yet little is known about the molecular functional mechanisms of these SNPs. In this study we investigated whether
dyslexia candidate SNPs have a direct, disease-specific effect on local expression levels of the assumed target gene
by using a differential allelic expression assay. In total, 12 SNPs previously associated with dyslexia and related phe-
notypes were suitable for analysis. Transcripts corresponding to four SNPs were sufficiently expressed in 28 cell
lines originating from controls and a family affected by dyslexia. We observed a significant effect of rs600753 on ex-
pression levels of DYX1C1 in forward and reverse sequencing approaches. The expression level of the rs600753
risk allele was increased in the respective seven cell lines from members of the dyslexia family which might be due to
a disturbed transcription factor binding sites. When considering our results in the context of neuroanatomical dys-
lexia-specific findings, we speculate that this mechanism may be part of the pathomechanisms underlying the dys-
lexia-specific brain phenotype. Our results suggest that allele-specific DYX1C1 expression levels depend on genetic
variants of rs600753 and contribute to dyslexia. However, these results are preliminary and need replication.
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Introduction
Dyslexia is a highly heritable disorder. The genetic
component contributes by up to 60% to this disorder
(Schulte-Körne, 2010) and several genes are suggested to
affect the development of dyslexia (see Tables S1 and S2).
Variants of well-validated genes such as DCDC2 (Dou-
blecortin Domain Containing 2), KIAA0319, ROBO1
(Roundabout Guidance Receptor 1) and DYX1C1 (Dys-
lexia Susceptibility 1 Candidate 1) are believed to be
involved in disturbed neuronal migration and axonal guid-
ance (Carrion-Castillo et al., 2013) as well as differences of
brain phenotypes such as alterations in white matter struc-
ture (Darki et al., 2012). In contrast to relatively well-
established knowledge on the gene level, information re-
garding the molecular mechanisms of dyslexia candidate
single nucleotide polymorphisms (SNPs) is still fragmen-
tary.
The molecular mechanism exerted by a certain SNP
can be of different nature. On the one hand, SNPs might af-
fect the structure of a gene-derived protein. For dyslexia,
however, only very few nonsynonymous SNPs affecting
protein structure and function are known (see Table S2 for
an overview). On the other hand, SNPs might influence the
protein quantitatively, e.g., by altering gene expression lev-
els, a phenomenon also referred to as expression quantita-
tive loci (eQTL). eQTLs are commonly differentiated in
cis-, as well as in trans-acting eQTLs. Trans eQTLs are lo-
cated distant to the gene which expression is affected and
cis eQTLs are located close to the affected gene.
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Only few studies specifically analyzed the impact of
dyslexia candidate SNPs on gene expression levels. Two
groups (Tapia-Páez et al., 2008; Tammimies et al., 2012)
reported a putative effect of rs3743205 on expression level
of DYX1C1. Tammimies et al. (2012) observed that a CpG
site results from the G-allele of this SNP. This might lead to
methylation of a transcription factor binding site, and, con-
sequently, in disturbed binding of transcription factors.
Paracchini et al. (2006) observed reduced expression levels
of KIAA0319 in carriers of the risk haplotype rs4504469-
rs2038137-rs2143340. In a second study, Dennis et al.
(2009) tested seven SNPs of the KIAA0319 promotor re-
gion and observed reduced KIAA01319 expression levels
for the minor allele rs9461045-T. However, these experi-
ments were all carried out in cells derived from donors
without dyslexia background. Such approaches might miss
effects resulting from a disease-specific genetic back-
ground. Previous results from dyslexia, but also from other
complex diseases, motivate to analyze such effects. For ex-
ample, Hannula-Jouppi et al. (2005) observed disease-
specific gene-expression levels in dyslexia and Furney et
al. (2011) identified an Alzheimer-specific effect for a SNP
within ZNF292 on entorhinal cortical volume. A disease-
specific molecular mechanisms can be understood as an ef-
fect which only emerges in affected individuals. This might
be due to different regulatory networks present in the af-
fected individuals. Consequently, certain molecular factor
might be active in the affected individuals, only, e.g., cer-
tain transcription factors. If a certain SNP would alter the
genomic binding site of such a disease specific factor, the
effect of this SNP would be also disease-specific, i.e., ob-
served only in the affected individuals (de la Fuente, 2010).
Another problem that may affect detection of an ef-
fect of a genetic variant on gene expression might result
from general heterogeneity across samples from a variety
of biological and technical sources, what can decrease
study power. However, these limitations can be addressed
by the direct measurement of cis-regulated allelic expres-
sion differences by differential allelic expression (DAE)
(Serre et al., 2008). In this approach, expression differences
resulting from the two different alleles of a SNP are ana-
lyzed within heterozygous individuals. Consequently, this
method is rather robust to biological or technical batch ef-
fects among individuals.
In our study we conducted a stepwise approach to
identify dyslexia-specific effects of SNPs on gene expres-
sion. We started with the identification of suitable dyslexia
candidate SNPs having a potential effect on local gene ex-
pression levels by assigning functional properties (Mc-
Laren et al., 2010) (Tables S1 and S2). Subsequently, all
these SNPs were genotyped in 10 cell lines derived from
multiple members of a family in which dyslexia frequently
occurred, thus providing a disease-specific background,
and in 18 control cell lines. Disease-specific DAE was as-
sessed in two replicates applying forward and reverse
Sanger sequencing of reverse transcribed cDNA. Results
were compared with publically available (dyslexia-uns-
pecific) eQTL-data.
Materials and Methods
SNP selection, cell lines and characterization steps
For the identification of dyslexia candidate SNPs, we
conducted a systematic screening using ‘PubMED’ and
‘Google Scholar’ for genetic candidate-studies related to
dyslexia. The identified SNPs had to map to an exonic,
5’-UTR or 3’-UTR location to have the potential to affect
local expression levels of the target genes. For each of these
SNPs, a minimum of four heterozygous cell lines per group
was required to maintain validity of our analyses (Serre et
al., 2008), and the general (non-allele specific) expression
of the SNP-corresponding transcripts was tested with
cDNA-specific primers in the sample cells of interest.
In total, 28 Epstein-Barr virus (EBV) immortalized
cell lines derived from B-cells were available. Ten cell lines
were derived from a three generational German family, in
which dyslexia segregation suggests a full-penetrance,
autosomal dominant inheritance. A genome-wide linkage
analysis revealed a haplotype of chromosome 12 co-segre-
gating with language impairment (Addis et al., 2010). For a
detailed description of the family see Addis et al. (2010). 18
cell lines that served as controls were derived from several
families with more details available elsewhere (Burkhardt
et al., 2012).
Extraction of genomic DNA (DNeasy Blood & Tis-
sue Kit, Qiagen, Hilden, Germany) and subsequent geno-
typing was performed by the matrix-assisted laser desor-
ption/ionization time-of-flight spectrometry system iPLEX
(Agena, Hamburg, Germany). SNPs had to fulfill Hardy-
Weinberg-Equilibrium criteria (HWE; p > 0.05 after Bon-
ferroni correction), and to exhibit a SNP-wise call rate >
97%, as well as a minor allele frequency (MAF) > 0.05.
SNPs had to be heterozygous in at least four individ-
ual cell lines to be eligible for analysis. Six SNPs fulfilled
this criterion and were considered for further analyses. Ap-
propriate cDNA-specific primers were designed and tested
for blood-specific expression. Gel electrophoresis demon-
strated sufficient expression of four SNPs in B-cells and
were therefore analyzed for DAE. Figure 1 illustrates the
workflow.
Heterozygous samples were quantified on cDNA and
gDNA level. cDNA was reverse-transcribed from RNA us-
ing Direct-zol RNA MiniPrep (Zymo Research, Irvine, CA,
USA) and Oligo(dT)15 primer (Promega, Madison, Wis-
consin, USA). Exonic, cDNA-specific PCR primers, and
gDNA-specific, intronic PCR primers were designed as
flanking the four SNPs. PCR was carried out with 45
rounds and 58 °C annealing temperature. For further de-
tails, see Wilcke et al. (2009) and Müller et al. (2016). To
quantify DAE, genomic and coding PCR products harbor-
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ing the SNP of interest were purified (Qiaquick PCR Purifi-
cation Kit, Qiagen, Hilden, Germany) and Sanger-sequen-
ced by Seqlab (Göttingen, Germany). Relative peak heights
of the SNP of interest were quantified using R software ver-
sion 3.2.4 (R Core Team, 2016) applying the add-on pack-
age sangerseqR version 1.4.0 (Hill et al., 2014). Allelic ra-
tios were calculated and log-transformed (see Figure 2).
For each SNP, the log-transformed allelic ratio was cor-
rected in an assay-specific manner (forward or reverse) by
subtracting the respective average transformed gDNA ra-
tio. Primer sequences can be found in Table S3.
Statistical analyses
To identify a genetic effect on gene expression, we
used the Kruskal-Wallis test to analyze significant differ-
ences between the allelic ratios of three groups: (i) affected
dyslexia family, (ii) controls, and (iii) gDNA. We used the
pairwise Wilcoxon rank sum test as post-hoc test, applying
the closed test procedure to account for multiple testing.
Results from forward and reverse sequencing were ana-
lyzed separately as well as combined by averaging allelic
log-ratios.
In silico characterization and comparison with
reported eQTLs
SNPs were characterized in silico according to
Ensembl annotations and prediction data (McLaren et al.,
2010). Furthermore, SNPs were annotated with known and
predicted regulatory elements including binding sites of
transcription factors and promoter regions using Regu-
lomeDB (Boyle et al., 2012). Publication-based (dyslexia-
unspecific) eQTLs comparison was performed by screen-
ing 24 published eQTL datasets (Dixon et al., 2007; Myers
et al., 2007; Veyrieras et al., 2008; Heinzen et al., 2008;
Ding et al., 2010; Liu et al., 2010; Murphy et al., 2010;
Zeller et al., 2010; Gibbs et al., 2010; Barreiro et al., 2011;
Borel et al., 2011; Fehrmann et al., 2011; Grundberg et al.,
2011; Kompass and Witte, 2011; Qiu et al., 2011; Innocenti
et al., 2011; Xia et al., 2012; Zou et al., 2012; Kim et al.,
2012; Kabakchiev and Silverberg, 2013; Westra et al.,
2013; Ramasamy et al., 2014; Kirsten et al., 2015; GTEx
Consortium, 2015). These publications cover a broad range
of 63 different tissues, including brain and neuronal tissues,
as well as cis and trans eQTL data.
The LD structure of the DYX1C1 locus was analyzed
via local association plots using LocusZoom software
(Pruim et al., 2011).
Results
Functional variant annotation and identification of
eligible SNPs
We identified 12 suitable SNPs with reported associa-
tions with dyslexia related phenotypes that have the poten-
tial to affect local expression levels: rs934634-CYP19A1,
rs10046-CYP19A1 and rs555879-MYO5B are located in the
3’-UTR, rs3743205- DYX1C1, rs2038137-KIAA0319 and
rs3178-NRSN1 are located in the 5’-UTR. Rs600753-
DYX1C1, rs17819126-DYX1C1, rs9467075-DCDC2,
rs3734972-FLNC and rs4504469-KIAA0319 are exonic
SNPs, and rs2143340-TDP2 is located in a non-coding
exon. Genotyping of these SNPs was performed in all 28
cell lines in order to identify heterozygous cell lines.
In a second step, SNPs were only considered for anal-
yses if a minimum of three heterozygous cell lines from the
dyslexia family as well as control cell lines were available.
Six of the preselected SNPs fulfilled this criterion
(rs10046-CYP19A1 (6 dyslexia and 11 controls),
rs934634-CYP19A1 (4 dyslexia and 9 controls),
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Figure 1 - Workflow of SNP characterization. Candidate SNPs used in this study had to be heterozygous in at least three immortalize B-cell lines originat-
ing from the dyslexia family and three cell lines originating from controls and expressed in the immortalized B-cells.
Figure 2 - Formula for calculating the log-transformed allelic ratio. The
allelic ratio is the difference between the natural logarithm-transformed
ratios of the allele heights of the cDNA and the gDNA.
rs9467075-DCDC2 (5 dyslexia and 8 controls),
rs600753-DYX1C1 (7 dyslexia and 10 controls),
rs555879-MYO5B (7 dyslexia and 14 controls),
rs2143340-TDP2 (4 dyslexia and 7 controls)).
In a third step, sufficient expression of the transcripts
corresponding to the SNPs in EBV cells was tested by
cDNA-specific PCR. Four SNPs fulfilled these three crite-
ria (rs10046-CYP19A1, rs600753-DYX1C1, rs934634-
CYP19A1, rs9467075-DCDC2) and, thus, were tested for
dyslexia-specific effects on gene expression (Figure 1).
Finally, sequences must have passed quality control.
Hence, for rs600753, data from up to six dyslexics and
seven controls, were included in differential allelic expres-
sion analysis. For detailed numbers see Table S4.
Differential allelic expression
No genetic effects on gene expression were observed
for variants rs10046-CYP19A1, rs934634-CYP19A1,
rs9467075-DCDC2. In contrast, we observed a significant
effect of rs600753 on DYX1C1 expression levels (Table 1
and Figure 3; raw-data is shown in Figure 4). In particular,
an effect of rs600753 on the forward sequencing based
measurement was observed (p=0.016). The post-hoc test
revealed significant differences between the cDNA levels
of the dyslexia family and the controls. The significant dif-
ference could be confirmed in data from reverse sequenc-
ing (p=0.013), as well as within the combined analyses of
both approaches (p=0.021). This showed that the reported
dyslexia risk-allele (rs600753-C) was expressed higher
than the protective allele (T) in the dyslexia family. The
control cell lines revealed the opposite effect, as the T-
allele was higher expressed compared to the C-allele (Table
1).
Since a single previous study reported sex-specific
association of rs600753 with dyslexia (Dahdouh et al.,
2009), we stratified our DAE analysis of rs600753 for sex.
However, we did not observe any sex-specific effect. The
risk and non-risk individuals revealed a similar genetic ef-
fect on gene expression for both sexes.
Functional annotation
Rs600753 was annotated with regulatory elements
using RegulomeDB which includes the identification of
transcription factor binding sites and their disturbance by
position weight matrix (PWM). PWM indicates the distur-
bance of binding sites the transcription factor Srf, Nanog,
Mtf1 by rs600753 (Matys et al., 2006; Badis et al., 2009;
Boyle et al., 2012). Furthermore, the publication-based an-
notation with eQTL-effects revealed an cis effect of
rs600753 on the expression levels of CCPG1 and PIGB in
blood derived cells (Xia et al., 2012; Westra et al., 2013;
Kirsten et al., 2015), and DYX1C1 in fibroblasts (GTEx
Consortium, 2015).
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Figure 3 - Differential allelic expression (DAE) of four dyslexia-related SNPs. Shown are allelic log-ratios measured in heterozygous samples adjusted
for the gDNA allelic ratio. a) Forward sequencing analysis of all four expressed SNPs stratified for cDNA allelic ratios for controls and the dyslexia af-
fected family and the logarithm of the gDNA allelic ratio. b) Reverse sequencing based replication of rs600753. c) Analysis of both sequencing ap-
proaches together. *p < 0.05 (Wilcoxon rank sum test). Global testing for genetic effects on gene expression of rs600753-DYX1C1 applying
Kruskal-Wallis test was always p < 0.05. For details see Table 1.
Figure 4 - Sequencing results of dyslexia family and controls. The rs600753 cDNA-sequences and the respective gDNA-sequences for six dyslexia fam-
ily members (a) and seven controls (b). Arrows indicate position of rs600753.
Discussion
This study analyzed dyslexia candidate SNPs with re-
gard to their disease-specific effect on the expression levels
of their respective gene. This was performed by applying a
DAE analysis of cells from a dyslexia family and controls.
SNP rs600753 indicated an effect on the expression level of
DYX1C1 with the reported risk allele rs600753-C (Dah-
douh et al., 2009; Matsson et al., 2015) being stronger ex-
pressed in cell lines derived from a dyslexia family as
compared to cell lines from controls.
Association of rs600753 with dyslexia related pheno-
types was first reported by Dahdouh et al. (2009) who iden-
tified an association of a haplotype spanning rs3743205,
rs3743204 and rs600753 in females. Variant rs600753 effi-
ciently tags this haplotype. Corroborating, a nominally sig-
nificant single-marker association of SNP rs600753 with
spelling was identified in German dyslexia families (Mats-
son et al., 2015). Our study further supports a role of
rs600753 in dyslexia as we found disease-specific effects
of rs600753 on expression levels of DYX1C1.
A distinction must be drawn between disease-specific
effects, such as those investigated here, and general, non-
disease-specific effects. The disease-specific effect of
rs600753 identified in this study can be explained by the
complex genetic background underlying the disease. Af-
fected individuals might exhibit changes in regulatory net-
works. This may lead, e.g., to the activation of transcription
factors that are not active in unaffected controls. If a SNP
causes a differential allelic expression of a binding site of a
such factor, the effect of the SNP can be disease-specific.
To the best of our knowledge, there is only one report of a
SNP affecting gene expression levels in a dyslexia-specific
manner. Hannula-Jouppi et al. (2005) observed allele-
specific expression of a SNP in the 3’-UTR of ROBO1
(6483T > A) in a dyslexic Finnish family. The expression
of the A-allele was absent or attenuated in four individuals.
However, the same group was unable to directly replicate
this finding in a more recent study (Massinen et al., 2016),
but the conclusion remained that adequate ROBO1 expres-
sion is a prerequisite for a normal crossing of the auditory
pathway (Lamminmäki et al., 2012; Massinen et al., 2016).
We aimed to control for such variations by analyzing both
strands.
Other studies investigated an effect of dyslexia candi-
date SNPs on gene expression levels in non-dyslexic sam-
ples, only. For instance, two studies reported effects of
rs3743205 on the expression levels of DYX1C1 (Tapia-
Páez et al., 2008; Tammimies et al., 2012). Similar results
were reported for KIAA0319. Reduced expression levels
were observed for the haplotype rs4504469-rs2038137-
rs2143340 (Paracchini et al., 2006) and for rs9461045
(Dennis et al., 2009). We tested the expression of
KIAA0319 with rs2038137, yet this gene was not expressed
in the available cell lines. Furthermore, risk allele fre-
quency of rs3743205-DYX1C1 was not sufficient in our
sample. Consequently, from our study we cannot draw con-
clusions concerning genetic effects on gene expression of
these SNPs.
In cell lines from the dyslexia family we observed
significantly increased expression associated with the re-
ported risk variant rs600753-C. Thereby we observed indi-
vidual differences in the effect size (Figures 2), which is
potentially due to a number of reasons. These include envi-
ronmental factors and the presence of additional genetic
factors modulating DYX1C1 expression levels. It certainly
would be of interest to see whether a generally increased
DYX1C1 expression level is present in the investigated dys-
lexia family including the non-carriers of the rs600753 risk
variants. However, this comparison is not available due to
the low number of available homozygous individuals.
The impact of altered gene expression levels on
neuronal function was repeatedly observed for the best rep-
licated dyslexia candidate genes (DCDC2, DYX1C1 and
KIAA0319). Knockdown experiments for these genes in
rats revealed disrupted neuronal migration to the neocortex
(Adler et al., 2013). Particularly, neurons from Dyx1c1
knockdown rats exhibited bimodal ectopic locations by re-
maining at the white matter border or migrating beyond
their expected position (Currier et al., 2011). Similar ecto-
pic neuronal locations were also observed in brains of dys-
lexic individuals (Galaburda et al., 1985). We speculate
that rs600753-DYX1C1 is part of the pathomechanism un-
derlying the characteristic dyslexia phenotype described by
Galaburda et al. (1985): Expression levels of genes being
relevant for neurogenesis need to be strictly controlled, and
too low as well as too high expression can be deleterious
(Francesconi and Lehner, 2014). Thus, allele-specific alter-
ations of DYX1C1 expression levels linked to rs600753
might have the potential to disturb downstream effects of
DYX1C1, such as neuronal migration and neuronalplace-
ment, and thereby affecting functionality of the resulting
neural networks.
PWM-assays support this hypotheses as they indi-
cated a disturbance of binding sites of three different tran-
scription factors (Srf, Nanog, Mtf1) by rs600753 (Matys et
al., 2006; Badis et al., 2009; Boyle et al., 2012). Altered
binding of these transcription factors might provide a mo-
lecular mechanism for the observed genetic regulation. Srf
(OMIM 600589) is an ubiquitous nuclear protein known to
be involved in cell growth, Mtf1 (OMIM 600172) is in-
volved in metal homeostasis and Nanog (OMIM 607937) is
involved in embryonic stem cell proliferation and renewal.
Hence, among these three putative affected transcription
factors we consider Nanog as the most interesting candi-
date in the context of the molecular pathomechanism of
dyslexia as its function provides a direct link to early devel-
opmental processes critical in dyslexia.
We analyzed published eQTL-data of unaffected
populations to obtain further insights into the observed
rs600753-DYX1C1 effect. Rs600753 directly affects the
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expression levels of CCPG1 and PIGB in blood derived
cells (Xia et al., 2012; Westra et al., 2013; Kirsten et al.,
2015), and DYX1C1 in fibroblasts (GTEx Consortium,
2015). The reported effect direction is in line with the direc-
tion we observed for the control cell lines (higher expressed
T-allele). This strengthens the hypothesis that the effect of
rs600753 is dyslexia-specific since we observed a signifi-
cant opposite effect direction in cells from the dyslexia
family (higher expressed C-allele).
However, rs600753 is not the strongest reported
eQTL at this locus (Figure S1), as reported effects of
rs12324434 are stronger (p=4.510-16). This variant is in
moderate linkage disequilibrium (R2=0.67) with rs600753
(GTEx Consortium, 2015). Notably, two studies analyzed
an association of rs12324434 with dyslexia but found no
association (Bates et al., 2010; Paracchini et al., 2011).
Therefore, in contrast to rs600753, a putative relevance of
rs12324434 for dyslexia remains to be shown.
Limitations
We investigated DAE in immortalized B-cells and
not in neuronal cell lines. However, it is well known that
most cis eQTL are ubiquitous, as typically more than 50%
are replicable among tissues (Van Nas et al., 2010; GTEx
Consortium, 2015). All investigated affected individuals
originated from a single, large dyslexia family, which lim-
its the generalizability of our observation. Hence, our find-
ings should be considered as preliminary and provocative
and should be replicated in larger numbers of affected and
unaffected individuals. Nevertheless, this family was very
well characterized for any medical conditions, and dyslexia
was the primary characteristic. Hence, we expect that the
described genetic effects on gene expression is likely of
dyslexia-specific nature. In line with this, when stratifying
our data of rs600753 for affection with dyslexia, an even
higher DAE was observed in cells originating from family
members with reported dyslexia compared with family
members without reported dyslexia (Figure S2). Moreover,
all investigated cell lines originated from individuals of
Caucasian ancestry. Although this eliminates an important
source of false positives due to population stratification,
this limits at the same time the transferability of our find-
ings to other ethnicities.
Conclusion
We identified allele-specific DYX1C1 expression lev-
els related to rs600753 in dyslexics, a variant previously re-
ported to be associated with dyslexia. Our findings are
among the first for dyslexia candidate SNPs suggesting an
effect on gene expression in a dyslexia-specific manner.
The results are in line with reported eQTL data and provide
further insights into the molecular pathomechanisms of
dyslexia.
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